140 related articles for article (PubMed ID: 6245504)
1. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
Margalith M; Manor D; Usieli V; Goldblum N
Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
[No Abstract] [Full Text] [Related]
2. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
3. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
Manor D; Margalith M
Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate.
Rickinson AB; Epstein MA
J Gen Virol; 1978 Aug; 40(2):409-20. PubMed ID: 211188
[TBL] [Abstract][Full Text] [Related]
5. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
Thorley-Lawson DA; Strominger JL
Virology; 1978 May; 86(2):423-31. PubMed ID: 208257
[No Abstract] [Full Text] [Related]
6. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
Datta AK; Hood RE
Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
[TBL] [Abstract][Full Text] [Related]
8. On the continuous culturing of B.95-8 cells in the presence of phosphonoacetic acid.
Margalith M; Manor D; Goldblum N
J Virol Methods; 1980; 1(6):349-54. PubMed ID: 6262340
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
Patel P; Menezes J
Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
[No Abstract] [Full Text] [Related]
10. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
[TBL] [Abstract][Full Text] [Related]
11. Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.
Lemon SM; Hutt LM; Pagano JS
J Virol; 1978 Jan; 25(1):138-45. PubMed ID: 202732
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the induction of virus-associated nuclear antigen and early antigen by lymphocyte-transforming (B95-8) and nontransforming (P3HR-1) strains of Epstein-Barr virus.
Menezes J; Patel P; Dussault H; Bourkas AE
Intervirology; 1978; 9(2):86-94. PubMed ID: 201584
[No Abstract] [Full Text] [Related]
13. Organophosphorous compounds as inhibitors of EBV infection and transformation.
Margalith M; Manor D; Goldblum N
Dev Biol Stand; 1982; 52():515-26. PubMed ID: 6299860
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Epstein-Barr virus DNA polymerase with aphidicolin, phosphonoformate and 5'-GMP.
Li JS; Cheng YC
Virus Genes; 1988 Jul; 1(4):369-75. PubMed ID: 2852412
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
Goodrich JM; Lee KW; Hinze HC
Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cytomegalovirus late antigens by phosphonoformate.
Wahren B; Oberg B
Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
[TBL] [Abstract][Full Text] [Related]
17. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
Casareale D; Jones W; Sairenji T; Humphreys RE
Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
Summers WC; Klein G
J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
Schnürer J; Oberg B
Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
[TBL] [Abstract][Full Text] [Related]
20. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Williams MV; Holliday J; Glaser R
Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
